Anders Høgset
Chief Tech/Sci/R&D Officer at PCI BIOTECH HOLDING ASA
Network origin in Anders Høgset first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
Nycomed ASA
2
| Extinct | Medical Specialties | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anders Høgset via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PROBI AB | Biotechnology | Director/Board Member | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| University of Stockholm | College/University | Masters Business Admin | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| ARCTICZYMES TECHNOLOGIES ASA | Medical Specialties | President Director/Board Member | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Doctorate Degree | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Undergraduate Degree Graduate Degree | |
| BI Norwegian Business School | College/University | Chairman Graduate Degree Graduate Degree | |
PricewaterhouseCoopers AS
 PricewaterhouseCoopers AS Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AS provides audit, advisory, accounting, tax, and legal services. It offers its expertise to the following industries: bank and finance, energy, health, industry and commerce, oil and gas, public sector, real estate, shipping, and telecom and media. The company was founded by Olav Ildal in 1939 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
siRNAsense AS
 siRNAsense AS Miscellaneous Commercial ServicesCommercial Services siRNAsense AS focuses on developing pipeline drugs. Its sources projects include Biotechnology Centre of Oslo, Centre for Molecular Biology and Neuroscience, Rikshospitalet-Radiumhospitalet HF and University of Oslo. The company was founded in December 2004 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Norwegian Academy of Science & Letters
 The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Chemlex AS | Director/Board Member | ||
| Biomedical Innovation AS | Director/Board Member | ||
| Biotechnology Centre of Oslo | Director/Board Member | ||
Oslo universitetssykehus HF
 Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Corporate Officer/Principal | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chief Executive Officer | |
SpinChip Diagnostics AS
 SpinChip Diagnostics AS Electronic Equipment/InstrumentsElectronic Technology SpinChip Diagnostics AS develops a game changing and proprietary platform for in vitro diagnostics point of care analyses. Its point of care device will satisfy all key user requirements, both with respect to assaying performance and user-friendliness. The firm's platform combines swift analysis and ease of use with wide range of advanced analyses. The company was founded by Stig Morten Borch in February 2012 and is headquartered in Oslo, Norway. | Electronic Equipment/Instruments | Chairman Director/Board Member | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Executive Officer | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Centre For Molecular Medicine Norway | Director/Board Member | ||
| CYXONE AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
PCI Biotech AS
 PCI Biotech AS BiotechnologyHealth Technology Part of PCI Biotech Holding ASA, PCI Biotech AS is a Norwegian company that engages in research and development in biotechnology. The private company is based in Lysaker, Norway. | Biotechnology | Director/Board Member | |
| EXACT THERAPEUTICS | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
| Herder Consulting AB | Director/Board Member | ||
| Tappin AS | Director/Board Member | ||
| Glycovisc BioTech AB | Corporate Officer/Principal | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member | |
| Alertis AS | Director/Board Member | ||
| Afiew AS | Director/Board Member |
Statistics
International
| Norway | 29 |
| Sweden | 18 |
| Denmark | 3 |
| Ireland | 2 |
| Netherlands | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 7 |
| Commercial Services | 7 |
| Finance | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 113 |
| Corporate Officer/Principal | 43 |
| Chairman | 32 |
| Independent Dir/Board Member | 28 |
| Chief Executive Officer | 26 |
Most connected contacts
- Stock Market
- Insiders
- Anders Høgset
- Company connections